Retour sur lavenir.net
   SYENSQO 56.800 € (+2,16 %)     SOFINA 220.800 € (+0,36 %)     LOTUS BAKERIES 10 040.000 € (0,00 %)     AB INBEV 62.780 € (+1,00 %)     FAGRON 23.700 € (+0,42 %)     D'IETEREN GROUP 177.600 € (+0,57 %)     ELIA GROUP 140.100 € (+0,14 %)     ARGENX SE 662.000 € (-0,63 %)     MELEXIS 71.150 € (+1,35 %)     MONTEA 71.400 € (+0,56 %)     UCB 237.200 € (-0,75 %)     HOME INVEST BE. 19.100 € (+0,63 %)     TUBIZE-FIN 203.000 € (-0,59 %)     SHURGARD 26.600 € (+0,76 %)     AEDIFICA 73.350 € (+0,48 %)     UMICORE 17.210 € (+0,94 %)     RECTICEL 9.960 € (+0,40 %)     SOLVAY 27.720 € (+0,80 %)     ATENOR 1.720 € (-4,71 %)     BREDERODE 102.800 € (+0,19 %)     KINEPOLIS GROUP 30.200 € (+5,04 %)     COLRUYT 33.100 € (-0,60 %)     TEXAF 44.600 € (+4,21 %)     XIOR 27.550 € (+0,36 %)     KBC ANCORA 77.200 € (+0,65 %)     CARE PROPERTY INV. 12.940 € (+0,78 %)     BIOTALYS 2.765 € (+18,67 %)     AGEAS 67.800 € (-0,15 %)     PROXIMUS 6.655 € (+0,08 %)     VASTNED 30.100 € (-0,33 %)     CIE BOIS SAUVAGE 324.000 € (-0,61 %)     ACKERMANS V.HAAREN 275.200 € (0,00 %)     WDP 23.900 € (+0,67 %)     RETAIL ESTATES 69.200 € (+0,29 %)     VGP 90.500 € (-0,22 %)     ONTEX GROUP 3.010 € (-0,17 %)     AZELIS GROUP 11.070 € (+0,27 %)     IBA 13.840 € (+0,44 %)     KBC 113.350 € (+0,58 %)     GBL 79.600 € (+0,06 %)     BARCO 9.445 € (+2,16 %)     HYLORIS 5.340 € (-1,84 %)     SIPEF 100.400 € (-0,40 %)     TESSENDERLO 21.350 € (+1,18 %)     COFINIMMO 86.050 € (+0,76 %)     CENERGY 21.900 € (+3,20 %)     BPOST 1.850 € (-1,39 %)     WERELDHAVE BELGIUM 53.600 € (-0,37 %)     NYXOAH 2.600 € (+1,17 %)     CFE 11.150 € (-1,76 %)     CAMPINE 214.000 € (0,00 %)     DEME GROUP 188.000 € (+0,32 %)     BELYSSE GROUP 0.634 € (+1,28 %)     CMB.TECH 11.180 € (+2,95 %)     DECEUNINCK 2.160 € (+1,41 %)     VAN DE VELDE 32.500 € (0,00 %)     BQUE NAT. BELGIQUE 388.000 € (+0,78 %)     TINC 11.900 € (+0,17 %)     GIMV 47.850 € (+0,84 %)     EVS BROADC.EQUIPM. 36.450 € (+0,69 %)  
   MINT 4.890 € (-1,41 %)     FDJ UNITED 25.320 € (+2,43 %)     ATON 0.023 € (+109,09 %)     ACCOR 43.480 € (+0,62 %)     RIBER 14.760 € (+6,65 %)     SOCIETE GENERALE 69.940 € (+1,13 %)     SAINT GOBAIN 77.960 € (+0,54 %)     EUROFINS SCIENT. 63.040 € (+2,01 %)     SCHNEIDER ELECTRIC 280.400 € (+1,59 %)     TOTALENERGIES 77.470 € (+0,61 %)     RENAULT 30.660 € (+3,02 %)     KALRAY 9.750 € (+16,77 %)     MEDIANTECHNOLOGIES 5.200 € (+6,89 %)     AIRBUS 166.320 € (+0,24 %)     STMICROELECTRONICS 43.135 € (-0,54 %)     PUBLICIS GROUPE SA 77.800 € (-0,28 %)     ADYEN 969.400 € (-0,58 %)     CAPITAL B 0.688 € (+2,66 %)     L'OREAL 377.800 € (+0,09 %)     EUROPLASMA 0.011 € (-18,46 %)     SHELL PLC 38.420 € (+0,76 %)     DSM FIRMENICH AG 64.400 € (0,00 %)     CSG 20.175 € (+1,24 %)     SANOFI 79.650 € (-0,54 %)     ESSILORLUXOTTICA 186.650 € (+0,51 %)     AIR LIQUIDE 189.260 € (+0,48 %)     EDENRED 21.470 € (-0,46 %)     ASML HOLDING 1 242.800 € (-0,54 %)     VALBIOTIS 0.978 € (-3,17 %)     TELEPERFORMANCE 54.560 € (+0,74 %)     AALBERTS NV 32.040 € (+1,26 %)     THX PHARMA 3.680 € (+2,79 %)     BNP PARIBAS ACT.A 90.420 € (+1,58 %)     THALES 231.500 € (-0,56 %)     CHRISTIAN DIOR 447.000 € (+0,72 %)     GECINA 72.700 € (+0,62 %)     MICHELIN 32.190 € (+0,78 %)     HEIJMANS KON 87.400 € (+0,75 %)     HAFFNER ENERGY 0.110 € (-21,14 %)     KAUFMAN ET BROAD 28.700 € (+0,53 %)     EDP RENOVAVEIS 14.020 € (+3,62 %)     Vusion 131.200 € (-1,72 %)     SAFRAN 273.600 € (+1,33 %)     SIGNIFY NV 20.420 € (+3,18 %)     EXOR NV 68.050 € (-0,29 %)     AXA 40.930 € (-0,24 %)     SOITEC 110.350 € (-2,04 %)     UBISOFT ENTERTAIN 4.943 € (+4,37 %)     RAPID NUTRITION 12.000 € (+4,35 %)     2CRSI 41.320 € (+1,92 %)     HIGH CO 3.670 € (-2,39 %)     PERNOD RICARD 65.500 € (-0,15 %)     OSE IMMUNO 3.680 € (+21,69 %)     ERAMET 55.750 € (+3,34 %)     GALP ENERGIA-NOM 19.545 € (+1,77 %)     HEINEKEN 66.300 € (-0,84 %)     DBV TECHNOLOGIES 3.516 € (+3,41 %)     CORBION 18.600 € (+0,59 %)     IMCD 98.500 € (+2,20 %)     BE SEMICONDUCTOR 251.500 € (-0,28 %)  
News Réglementées
27/04/2026 09:00

Original-Research: ATOSS Software SE (von NuWays AG): BUY

Original-Research: ATOSS Software SE - from NuWays AG

27.04.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to ATOSS Software SE

Company Name:ATOSS Software SE
ISIN:DE0005104400
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 134
Target price on sight of:12 months
Last rating change:
Analyst:Philipp Sennewald

Strong start into FY26; Guidance already upgraded

On Friday, ATOSS released strong Q1 results that confirmed the company's ability to compound top-line growth and profitability in parallel, prompting management to lift its full-year margin guidance already. In detail:

Group sales rose 11% yoy to € 51.4m (eNuW: € 51.9m), driven mainly by software (+13% yoy to € 38.3m). Once again, Cloud & Subscriptions accelerated significantly to € 27.0m (+27% yoy), now accounting for 53% of total sales (Q1 25: 46%), while license revenues continued their planned compression to just € 1.6m (-40% yoy), reflecting the ongoing successful migration of customers towards recurring cloud contracts. Together with maintenance, recurring revenues reached € 36.7m (+17% yoy), lifting the recurring share to 71%, reflecting a 3pp yoy improvement.

The cloud ARR trajectory remains the most important forward indicator. Cloud ARR grew 27% yoy to € 110m, supported by a net retention rate of 112% (+1pp yoy). The 12-month cloud order backlog rose 23% yoy to € 114m, while the total ARR backlog climbed 16% yoy to € 152.5m. New ACV came in at € 21.5m (flat yoy), with new logos accounting for ~50% of contracts signed. Healthcare is gaining additional traction as a vertical, contributing a significant share of new business. During the CC, management stated the flat ACV is in-line with budget and thus baked in the FY26 top-line guidance (c. € 215m). Should the current (macro-related) elongation of sales cycle ease, this could imply upside to the current outlook.

On profitability, EBIT reached € 18.2m, corresponding to a 35.3% margin (eNuW: € 17.9m), once more reflecting ATOSS' disciplined cost management and the operating leverage inherent in the SaaS model. A revaluation of the long-term incentive programme had a marginal accretive impact on the quarter. FCF surged 97% yoy to € 39.4m, reflecting front-loaded cloud billings and a normalisation of tax outflows vs. Q1 2025, which had been inflated by one-off back taxes. Liquidity reached € 162.1m, providing the company with ample strategic flexibility for further organic investments into AI or potential bolt-on acquisitions, while organic growth alone remains sufficient to drive value creation with ROICs well above 50%.

On AI, ATOSS targets two near-term deliverables: the agentic ATC assistant launching in Q2 2026 and thetwo new Agents for ASES, both due in Q4 2026. The latter allows workers to describe complex scheduling needs, even by voice, with the agent checking all applicable rules and surfacing compliant options autonomously. Strategically, AI is proving a pull-forward catalyst for cloud migration with early adoption trends across healthcare and retail suggesting the product roadmap is resonating with the installed base.

Management confirmed FY26 sales guidance of ~€ 215m and lifted the EBIT margin target to ≥34% (previously ≥32%), which we already flagged in previous notes and hence regard as reasonable given the strong start into the year.

Reiterate BUY with a new € 134 PT (old: € 148) based on DCF.

You can download the research here: atoss-software-se-2026-04-27-previewreview-en-13228
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2315116  27.04.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière